basem moosa

Dr. basem moosa


Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 December 2020 in Accounts of Chemical Research
Verified
Journal Article
Closed access
GZGengwu Zhang
Gengwu Zhang
BHBin Hua
Bin Hua
ADAvishek Dey
Avishek Dey
MGMunmun Ghosh
Munmun Ghosh
BMbasem moosa
basem moosa
NKNiveen Khashab
Niveen Khashab

8 October 2018 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
ACArnaud Chaix
Arnaud Chaix
Georges MouchahamGeorges Mouchaham
Georges Mouchaham
ASAleksander Shkurenko
Aleksander Shkurenko
PHPhuong Hoang
Phuong Hoang
BMbasem moosa
basem moosa
NKNiveen Khashab
Niveen Khashab

30 May 2023 in Nature Communications
Verified
Journal Article
Open access
XLXiang Li
Xiang Li
WLWeibin Lin
Weibin Lin
VSVivekanand Sharma
Vivekanand Sharma
RGRadoslaw Gorecki
Radoslaw Gorecki
MGMunmun Ghosh
Munmun Ghosh
SNSuzana Nunes
Suzana Nunes
The evolution of the chemical and pharmaceutical industry requires effective and less energy-intensive separation technologies. Engineering smart materials at a large scale with tunable properties for molecular separation is a challenging step to materialize this goal. Herein, we report thin film composite membranes prepared by the interfacial polymerization of porous organic cages (POCs) (RCC3 and tren cages). Ultrathin crosslinked polycage selective layers (thickness as low as 9.5 nm) are obtained with high permeance and strict molecular sieving for nanofiltration. A dual function is achieved by combining molecular separation and catalysis. This is demonstrated by impregnating the cages with highly catalytically active Pd nanoclusters ( ~ 0.7 nm). While the membrane promotes a precise molecular separation, its catalytic activity enables surface self-cleaning, by reacting with any potentially adsorbed dye and recovering the original performance. This strategy opens opportunities for the development of other smart membranes combining different functions and well-tailored abilities.

1 August 2017 in Journal of Controlled Release
Verified
Journal Article
Closed access
HOHaneen Waleed Omar
Haneen Waleed Omar
JCJonas Croissant
Jonas Croissant
KAKholod Alamoudi
Kholod Alamoudi
SAShahad Alsaiari
Shahad Alsaiari
IAIbrahim Alradwan
Ibrahim Alradwan
NKNiveen Khashab
Niveen Khashab

31 January 2014 in Anti-Cancer Agents in Medicinal Chemistry
Verified
Journal Article
Open access
SSSunil Sagar
Sunil Sagar
LELuke Esau
Luke Esau
BMbasem moosa
basem moosa
NKNiveen Khashab
Niveen Khashab
VBVladimir Bajic
Vladimir Bajic
MKMandeep Kaur
Mandeep Kaur
Plumbagin [5-hydroxy- 2-methyl-1, 4-naphthaquinone] is a well-known plant derived anticancer lead compound. Several efforts have been made to synthesize its analogs and derivatives in order to increase its anticancer potential. In the present study, plumbagin and its five derivatives have been evaluated for their antiproliferative potential in one normal and four human cancer cell lines. Treatment with derivatives resulted in dose- and time-dependent inhibition of growth of various cancer cell lines. Prescreening of compounds led us to focus our further investigations on acetyl plumbagin, which showed remarkably low toxicity towards normal BJ cells and HepG2 cells. The mechanisms of apoptosis induction were determined by APOPercentage staining, caspase-3/7 activation, reactive oxygen species production and cell cycle analysis. The modulation of apoptotic genes (p53, Mdm2, NF-kB, Bad, Bax, Bcl-2 and Casp-7) was also measured using real time PCR. The positive staining using APOPercentage dye, increased caspase-3/7 activity, increased ROS production and enhanced mRNA expression of proapoptotic genes suggested that acetyl plumbagin exhibits anticancer effects on MCF-7 cells through its apoptosis-inducing property. A key highlighting point of the study is low toxicity of acetyl plumbagin towards normal BJ cells and negligible hepatotoxicity (data based on HepG2 cell line). Overall results showed that acetyl plumbagin with reduced toxicity might have the potential to be a new lead molecule for testing against estrogen positive breast cancer.

18 October 2017 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
YZYang Zhang
Yang Zhang
PYPeng Yang
Peng Yang
MMMadathumpady Abubaker Habeeb Muhammed
Madathumpady Abubaker Habeeb Muhammed
SAShahad K. Alsaiari
Shahad K. Alsaiari
BMbasem moosa
basem moosa
NKNiveen Khashab
Niveen Khashab